Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase
โ Scribed by Tanya Meyer; LiHui Xu; Jinli Chang; Edison T. Liu; Rolf J. Craven; William G. Cance
- Book ID
- 102861744
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- French
- Weight
- 564 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Rak is a 54 kDa protein tyrosine kinase originally isolated from breast cancer cells and expressed in epithelial cells. It resembles the protooncogene Src structurally but lacks an aminoโterminal myristylation site and localizes to the nuclear and perinuclear regions of the cell. We report here that expression of Rak in 2 different breast cancer cell lines inhibits growth and causes G~1~ arrest of the cell cycle. This growth inhibition is kinaseโdependent but does not require the Rak SH2 or SH3 domain. Rak also binds to the pRb tumorโsuppressor protein but inhibits growth even in cells that lack pRb. These results suggest that Rak regulates cell growth by phosphorylating perinuclear proteins and has a function that is distinct from the Srcโrelated kinase family. ยฉ 2002 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr
Syk, a nonreceptor type of protein tyrosine kinase widely expressed in hematopoietic cells, is a candidate suppressor gene in human breast cancer. Reduced expression of Syk protein is correlated with poor prognosis, while its overexpression can reduce the malignant phenotype of breast cancer cells.